ACHL (Achilles Therapeutics) 3-Year Book Growth Rate : -9.40% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Achilles Therapeutics 3-Year Book Growth Rate?

Achilles Therapeutics's Book Value per Share for the quarter that ended in Sep. 2024 was $2.51.

During the past 12 months, Achilles Therapeutics's average Book Value per Share Growth Rate was -33.30% per year. During the past 3 years, the average Book Value per Share Growth Rate was -9.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 5 years, the highest 3-Year average Book Value per Share Growth Rate of Achilles Therapeutics was -9.40% per year. The lowest was -57.30% per year. And the median was -33.35% per year.

Competitive Comparison of Achilles Therapeutics's 3-Year Book Growth Rate

For the Biotechnology subindustry, Achilles Therapeutics's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Achilles Therapeutics's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Achilles Therapeutics's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Achilles Therapeutics's 3-Year Book Growth Rate falls into.

Achilles Therapeutics 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Achilles Therapeutics (NAS:ACHL) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Achilles Therapeutics 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Achilles Therapeutics's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Achilles Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achilles Therapeutics PLC (NAS:ACHL) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

698:Germany

Address

245 Hammersmith Road, London, GBR, W6 8PW

Website

https://www.achillestx.com

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.